The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 08, 2016

Filed:

Sep. 06, 2011
Applicants:

Kurt Schonfeld, Langen, DE;

Christiane Knopp, Langen, DE;

Winfried Wels, Frankfurt am Main, DE;

Inventors:

Kurt Schonfeld, Langen, DE;

Christiane Knopp, Langen, DE;

Winfried Wels, Frankfurt am Main, DE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/85 (2006.01); C07K 14/54 (2006.01); C07K 14/725 (2006.01); C07K 14/705 (2006.01); C12N 15/86 (2006.01); A61K 35/12 (2015.01);
U.S. Cl.
CPC ...
C12N 15/85 (2013.01); C07K 14/5443 (2013.01); C07K 14/7051 (2013.01); C07K 14/70517 (2013.01); C12N 15/86 (2013.01); A61K 2035/124 (2013.01); C07K 2319/02 (2013.01); C07K 2319/33 (2013.01); C07K 2319/74 (2013.01); C12N 2740/16043 (2013.01);
Abstract

The present invention relates to the use of interleukin-15 (IL-15) as selectable marker for gene transfer, preferably of at least one gene of therapeutic interest, into a mammalian cell or cell line, in particular a human cell or cell line. The present invention furthermore relates to transgenic mammalian cells or cell lines expressing IL-15 as selectable marker and co-expressing at least one protein of interest encoded by at least one gene of interest, which is preferably a protein of therapeutic interest. The present invention is in particular suitable for chimeric antigen receptors (CARs) as the gene or protein of interest and their expression in lymphocytes. The transgenic mammalian cells and cell lines are furthermore suitable for use as a medicament, in particular in the treatment of cancer and in immunotherapy, such as adoptive, target-cell specific immunotherapy.


Find Patent Forward Citations

Loading…